Vanguard Group Inc Vaxart, Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Vaxart, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 10,368,924 shares of VXRT stock, worth $4.46 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,368,924
Previous 10,077,418
2.89%
Holding current value
$4.46 Million
Previous $6.65 Million
36.08%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding VXRT
# of Institutions
102Shares Held
27.6MCall Options Held
14.3KPut Options Held
55.2K-
Sio Capital Management, LLC New York, NY5.58MShares$2.4 Million0.86% of portfolio
-
Geode Capital Management, LLC Boston, MA2.66MShares$1.14 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.77MShares$762,9680.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny956KShares$411,0220.0% of portfolio
-
Squarepoint Ops LLC New York, NY804KShares$345,9240.0% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $54.4M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...